Overview Artificial intelligence seems to be transforming drug discovery in 2026, enabling faster molecule design, smarter ...

AI could review data sets to assist clinical scientists ...

DUBLIN--(BUSINESS WIRE)--The "Human Factors and Usability Engineering in the Development of Drug Delivery Products Training Course 24" conference has been added to ResearchAndMarkets.com's offering.

Explore the role of BD&L in R&D decision-making. Understand its impact on funding and market intelligence for scientists.

Identifying and accelerating drug development is big business. The costs in this industry are significant and finding pathways to optimize using AI methods is top of mind in this fast and evolving ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

Duxin Sun receives funding from the NIH, FDA, and pharmaceutical industries including Bristol-Myers Squibb, Celgene Corporation, Aurinia Pharmaceuticals, Abbvie, Nanomedicine Innovation Center.

To join the CNBC Technology Executive Council, go to cnbccouncils.com/tec Scientists at Eli Lilly have been surprised by novel design of molecules that AI has ...

Two formative experiences shaped Craig Crews’ path into drug development. First, when he was still a child, his grandmother died from cancer at just 52 years old. “At the time, there weren’t very many ...

The most striking evidence that artificial intelligence can provide profound scientific breakthroughs came with the unveiling of a program called AlphaFold by Google DeepMind. In 2016 researchers at ...